Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-007547

Chief Business Development Off sold 6,770 shares at an average $55.65 ($376,720)

  • Chief Business Development Off acquired 6,770 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Exercise or conversion : show line 1 in the form +2,604 $6.55 $17,056 2,604 D
2021-02-01 Exercise or conversion : show line 2 in the form +2,604 $6.55 $17,056 5,208 D
2021-02-01 Exercise or conversion : show line 3 in the form +1,562 $7.27 $11,356 6,770 D
2021-02-01 Sale : show line 4 in the form −6,470 $55.61 $359,797 300 D
2021-02-01 Sale : show line 5 in the form −300 $56.41 $16,923 0 D
Open-market sales · 6,770 sh · avg $55.65 · $376,720

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-02-01 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −2,604 23,438 D
2021-02-01 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −2,604 52,084 D
2021-02-01 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −1,562 35,938 D
Loading xslF345X03/doc4.xml…